MedDataX Logo

Sarcopenia and Physical Performance in Hemodialysis Patients

NCT ID: NCT04669184

Last Updated: 2020-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

26 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-01

Study Completion Date

2022-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Many systems such as the cardiovascular, pulmonary, musculoskeletal, hematological, immunological, gastrointestinal, central nervous system are affected due to decreased kidney function. The aim of this study was to investigate the relationship between physical performance and sarcopenia, peripheral muscle strength, activities of daily living, cognitive functions, physical activity level, fragility, pain in hemodialysis patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A high prevalence of sarcopenia has been reported in end stage kidney disease. The incidence of sarcopenia increases with age. Muscle atrophy is caused by an imbalance between the anabolic and catabolic processes in chronic kidney disease. Sarcopenia and physical inactivity progress synergistically. Decreased physical performance is associated with sarcopenia. In hemodialysis patients, daily physical activity level and physical performance decrease. Cognitive impairment is common in chronic kidney disease. Uremic toxins can cause a decrease in cognitive function. One of the most important problems associated with hemodialysis is pain and pain negatively affects functional capacity and quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Kidney Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

sarcopenia pain physical performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having been diagnosed with end stage kidney disease
* Receiving hemodialysis for more than 3 months
* Being clinically stable
* Volunteering to participate in the research

Exclusion Criteria

* Having an orthopedic disease that may affect functional capacity
* Having cardiac event in the past 3 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hacettepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Merve Firat

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Merve Firat, MSc

Role: PRINCIPAL_INVESTIGATOR

Hacettepe University

Naciye Vardar-Yagli, PhD

Role: STUDY_DIRECTOR

Hacettepe University

Deniz İnal-İnce, Professor

Role: STUDY_CHAIR

Hacettepe University

Tolga Yildirim, MD

Role: STUDY_CHAIR

Hacettepe University

Melda Saglam, PhD

Role: STUDY_CHAIR

Hacettepe University

Ebru Calik-Kütükcü, PhD

Role: STUDY_CHAIR

Hacettepe University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Merve Firat

Role: CONTACT

Phone: +903123051576

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GO 20/338

Identifier Type: -

Identifier Source: org_study_id